News

Aggredyne Inc., has received ISO 13485 certification for its quality control program related to the manufacture of the AggreGuide family of platelet function analyzers.

Atherotech Diagnostics Lab has added three new genetic tests to its cardiometabolic test offering: warfarin sensitivity, Plavix sensitivity and the thrombophilia risk test.

 

Abbott promised preliminary results from a study presented at the ESC Congress 2013, suggesting that its high sensitive troponin test may help doctors improve the diagnosis and prognosis of...

Abbott announced results from a study evaluating its High Sensitive Troponin-I (hsTnI) assay. The study, conducted by researchers at Brigham and Women's Hospital, demonstrated that ...

Polymer Technology Systems Inc. has introduced the CardioChek Plus analyzer. It is a combination reflectance lipid and electrochemical glucose analyzer that delivers rapid test results for lipids...

T2 Biosystems announced the presentation of data strongly correlating T2Hemostat results with patients’ clinical outcomes. In 26 patients who presented with chest pain and underwent cardiac...

Clinical Study Aspirin Duke Medicine Blood Test Platelet Functioning Testing

Aspirin has been widely used for more than 50 years as a common, inexpensive blood thinner for patients with heart disease and stroke, but doctors have little understanding of how it works and why...

University of Maryland Medical Center Genetic-Testing Program Cardiac Stent

Patients with coronary artery disease who undergo treatment at the University of Maryland Medical Center (UMMC) now can receive long-term therapy based on information found in their genes. As part...

UK Blood Clots Teststing Wafarin Self Monitoring

A simple self-monitoring test could reduce the risk of stroke by half in thousands of people in the United Kingdom who currently take warfarin to prevent blood clots. Better access to self-...

The results of a pivotal benchmark study of Silicon BioDevices’ digital handheld device for high-sensitivity measure­ment of cardiac troponin-I, a protein found in the heart muscle used to...

Abbott has received Conformite Europeene (CE) marking for the Architect Galectin-3 assay, a blood test to aid doctors in assessing the prognosis of patients diagnosed with chronic...

Accumetrics Inc. VerifyNow P2Y12 Test Bleeding Ischemic Events

Accumetrics Inc. announced an expansion in the intended use for the CE marked VerifyNow P2Y12 Test. Physicians can now use the test results to assess whether a patient may be at greater risk for...

Nanomix Inc. has initiated clinical testing in the United States to evaluate the omega-3 cardiac panel.  The panel quantitatively tests whole blood specimens for levels of cardiac troponin I...

AspirinWorks Test Kit

Corgenix Medical Corp. has announced that Atherotech Diagnostics Lab will carry its AspirinWorks Test for determining aspirin effect.

Alere Inc. announced the results of research presented at the American College of Cardiology’s 62nd Annual Scientific Session, which showed that a simple screening and management program can be...

Accumetrics Verify Now ACC 2013 Antiplatelet Therapy Blood Testing Pharmaceutica

Accumetrics Inc. announced the presentation of a series of important data that solidifies the clinical utility of platelet reactivity testing. Real world outcomes data in high-risk patients...

Laboratory Corporation of America Holdings (LabCorp) announced it has launched its clinical next generation sequencing assay, GeneSeq: Cardio for genetic causes of familial cardiac disease.

January has been a month of change for Abbott, and a senior medical devices analyst from GlobalData asserts that the company’s latest cardiac diagnostics product represents the first step in a...

Abbot Vascualr Architect Stat Blood Testing Point-of-Care Testing

An estimated 17 million people throughout the world die annually of cardiovascular diseases, specifically heart attacks or strokes. Time is a critical factor in diagnosing and treating people who...

Accumetrics VerifyNow II CE mark Antiplatelet Therapy

Accumetrics Inc. announced that its next generation VerifyNow II System has achieved CE marking for point-of-care measurement of platelet reactivity to antiplatelet agents. This marks the...